Combined therapeutic effects of an immunomodulator, PSK, and chemotherapy with carboquone on rat bladder carcinoma
- 1 May 1985
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 15 (1) , 54-58
- https://doi.org/10.1007/bf00257295
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- BCG in the management of superficial bladder cancerUrology, 1984
- APPLICATION OF HUMAN LEUCOCYTE INTERFERON IN PATIENTS WITH URINARY BLADDER PAPILLOMATOSIS, BREAST CANCER, AND MELANOMAThe Lancet, 1981
- Experimental Study of Immunochemotherapy of Brain TumorsNeurologia medico-chirurgica, 1980
- Subcutaneous Corynebacterium parvum in Bladder CancerBritish Journal of Urology, 1979
- Effect of intralesional and systemic BCG-application or a combined cyclophosphamide/BCG treatment on experimental bladder cancerUrological Research, 1979
- Clinical Studies on PSK: Combination Therapy of PSK With Surgery and ChemotherapyPublished by Springer Nature ,1979
- IMMUNOCHEMOTHERAPY OF TRANSPLANTED KMT-17 TUMOR IN WKA RATS BY COMBINATION OF CYCLOPHOSPHAMIDE AND IMMUNOSTIMULATORY PROTEIN-BOUND POLYSACCHARIDE ISOLATED FROM BASIDIOMYCETES1977
- Effect of PS-K, a Protein Polysaccharide, on Pulmonary Metastases of a C3H Mouse Squamous Cell Carcinoma 2JNCI Journal of the National Cancer Institute, 1976
- Association of Anergy with an Immunosuppressive Peptide Fraction in the Serum of Patients with CancerNew England Journal of Medicine, 1974
- Protein-bound polysaccharide preparation, PS-K, effective against mouse sarcoma-180 and rat ascites hepatoma AH-13 by oral use.1974